The State Drug Administration approves the registration of Shanghai Songli Bio's innovative product "Composite Patch Patch"
-
Last Update: 2020-06-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
today, the StateDrug(the Supervisory Authority issued a notice) that, after examination, approved the Shanghai Songli Biotechnology LimitedCompany(developed innovativeproducts("composite patch patch" registrationcompound crucible patch patch is suitable for the open abdominal cavity outside the repair of groincompound crucible patch patch to L-propylene ester, hexende copolymer and pig-derived fibrinas as the common mixture as raw material, the use of electrostatic spinning technology made of composite patchcomposite crucible patch has a microporous stent structure, and the material grows human tissue inside the stent during degradation and repairs defectscompound crucible patch patch also has the characteristics of larger and hydrophilic than the surface area, which helps the patient to heal the related factors and cell adhesion
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
